首页> 外文期刊>International angiology: A journal of the International Union of Angiology >Effects of elastic stocking on quality of life of patients with chronic venous insufficiency. An Italian pilot study on Triveneto Region.
【24h】

Effects of elastic stocking on quality of life of patients with chronic venous insufficiency. An Italian pilot study on Triveneto Region.

机译:弹性袜对慢性静脉功能不全患者生活质量的影响。意大利对Triveneto地区的试点研究。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Even though compression therapy is the most recommended treatment for chronic venous insufficiency (CVI) in the national and international guidelines, its application, at least in Italy, is lower than the estimated need from the prevalence of CVI in the epidemiological studies. Since we believe that the measurement of the impact of compression therapy on quality of life (QoL) could improve the compliance for this precious treatment, we carried out this study on 50 patients with CVI. METHODS: Fifty patients (23 CEAP C2 and 27 C(3-4-5), selected within a larger study on QoL in CVI), received a prescription for compression therapy. Before treatment and 4 months afterwards, the patients received the instrument for QoL assessment (MOS SF-36; CIVIQ-2; Euro-QoL 5D and a visual analogue scale). The score scales have been adjusted to poorest QoL as 0 and best QoL as 100. RESULTS: Baseline QoL of patients in class C2 did not show significant difference with the healthy Italian Population, except for the physical role item. The patients in class C(3-4-5) showed significant reduction of QoL. After 4 months all the items of the utilized instrument showed significant improvement (from P<0.01 to P<0.04 for SF-36; from P<0.099 to P<0.006 for other instruments) in all CEAP classes. CONCLUSIONS: The study unquestionably shows that the compression therapy improves the QoL of patients with CVI, and should be included in the CVI treatment covered by the Public National Health Insurance. Finally, the QoL measurement could be utilized as the scientific method to assess the effectiveness and efficacy of different therapeutic devices.
机译:目的:尽管在国家和国际准则中,对于慢性静脉功能不全(CVI),最推荐使用压缩疗法,但至少在意大利,其应用低于流行病学研究中CVI患病率的估计需求。由于我们认为对加压疗法对生活质量(QoL)的影响进行测量可以提高这种珍贵疗法的依从性,因此我们对50例CVI患者进行了这项研究。方法:五十名患者(23名CEAP C2和27 C(3-4-5),在一项针对CVI中QoL的较大研究中选择)接受了压缩疗法处方。在治疗之前和之后4个月,患者接受了QoL评估仪器(MOS SF-36; CIVIQ-2; Euro-QoL 5D和视觉模拟量表)。已将评分量表调整为最差的QoL为0,最佳的QoL为100。结果:C2类患者的基线QoL与健康的意大利人口没有显着差异,除了身体角色。 C级(3-4-5)的患者表现出QoL的明显降低。 4个月后,在所有CEAP类别中,所用仪器的所有项目均显示出显着改善(对于SF-36,从P <0.01到P <0.04;对于其他仪器,从P <0.099到P <0.006)。结论:毫无疑问,该研究表明加压疗法可改善CVI患者的QoL,应将其纳入公共国民健康保险所涵盖的CVI治疗中。最后,QoL测量可以用作评估不同治疗设备的有效性和功效的科学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号